CeloNova announces interim results from randomized controlled trial evaluating 14-days DAPT in complex patients at high bleeding risk following PCI

Press/Media

Period	20 Oct 2020

Media coverage

Title	CeloNova announces interim results from randomized controlled trial evaluating 14-days DAPT in complex patients at high bleeding risk following PCI
Media name/outlet	PharmaBiz
Country/Territory	India
Date	20/10/20
URL	www.pharmabiz.com/NewsDetails.aspx?aid=132883&sid=2
Persons	Roxana Mehran,